BrainsWay Ltd. (TLV:BWAY)
2,753.00
+26.00 (0.95%)
Oct 26, 2025, 12:49 PM IDT
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
1.29M ILS
Profits / Employee
150.05K ILS
Market Cap
1.05B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120 | -14 | -10.45% |
| Dec 31, 2023 | 134 | 0 | - |
| Dec 31, 2022 | 134 | 16 | 13.56% |
| Dec 31, 2021 | 118 | 18 | 18.00% |
| Dec 31, 2020 | 100 | -7 | -6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 35,686 |
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| InterCure | 320 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
BrainsWay News
- 4 weeks ago - Do Options Traders Know Something About Brainsway Stock We Don't? - Nasdaq
- 5 weeks ago - BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care - Nasdaq
- 5 weeks ago - FDA Clearance Boosts BrainsWay (BWAY) Shares - GuruFocus
- 5 weeks ago - BrainsWay rises as FDA clears accelerated Deep TMS protocol - Seeking Alpha
- 5 weeks ago - BrainsWay (BWAY) Gains FDA Approval for Enhanced Depression Treatment Protocol - GuruFocus
- 2 months ago - BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - GlobeNewsWire
- 2 months ago - BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health - GlobeNewsWire
- 2 months ago - BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript - Seeking Alpha